Table 1.
Patient | Diagnosis | Operation | Interval (years) | Problem | Age (years) | Stent | Follow up (years) |
1 | HLHS | fen Fontan | 0.7 | Casts | 4.0 | J&J P308 | 3.4 |
2 | DILV TGA | Fontan | 7.2 | PLE | 13 | J&J P308 | 2.8 |
3 | DILV TGA | Fontan | 2.9 | PLE | 7.4 | J&J P188 | 2.3 |
4 | HLHS | fen Fontan | 0.5 | PLE | 4.6 | Jomed 17mm | 0.7 death |
5 | TGA | Arterial switch | 7.4 | PHT | 7.5 | J&J P188 | 1.2 |
6 | DILV, TGA, MS | – | PHT | 16 | J&J P308 | 0.8 | |
7 | DORV TGA | Fontan | 2.3 | PLE | 8.3 | J&J P308 | 3.1 |
8 | ccTGA, MA, PA | fen Fontan | 0.1 | LCO | 7.0 | J&J P188 | 1.9 closure |
9 | Primary PHT | – | PHT | 48 | J&J P188 | 0.1 HLTX | |
10 | Primary PHT | – | PHT | 62 | J&J P188 | 0.9 death | |
11 | Primary PHT | – | PHT | 72 | J&J P188 | 2.1 | |
12 | Primary PHT | – | PHT | 72 | J&J P188 | 1.8 |
Casts, bronchial casts; cc, congenitally corrected; DILV, double inlet left ventricle; fen, fenestrated; HLHS, hypoplastic left heart syndrome; HLTX, heart-lung transplantation; J&J, Johnson & Johnson; LCO, low cardiac output; MA, mitral atresia; MS, mitral stenosis; PA, pulmonary atresia; PHT, pulmonary hypertension; PLE, protein losing enteropathy; TGA, transposition of the great arteries.